Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Dual CAR-T cells to treat cancers co-expressing NKG2D and PD1 ligands in xenograft models of peritoneal metastasis.
Cancer Immunol Immunother. 2023 Jan;72(1):223-234. doi: 10.1007/s00262-022-03247-9. Epub 2022 Jul 9.
Cancer Immunol Immunother. 2023.
PMID: 35809118
Free PMC article.
T cells with split CARs specific for NKG2D ligands and PD-L1 exhibit improved selectivity towards monocyte-derived cells while effective in eliminating acute myeloid leukaemia in vivo.
Sun L, Jiang G, Ng YY, Xiao L, Du Z, Wang S, Zhu J.
Sun L, et al.
J Cancer Res Clin Oncol. 2023 Sep;149(12):10189-10201. doi: 10.1007/s00432-023-04865-1. Epub 2023 Jun 3.
J Cancer Res Clin Oncol. 2023.
PMID: 37270461
Item in Clipboard
Cite
Cite